The Effect of Dexamethasone on Cortisol Levels in Patients Undergoing Thyroid Surgery
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT01045876|
Recruitment Status : Withdrawn (Lack of resources)
First Posted : January 11, 2010
Last Update Posted : April 19, 2016
|Condition or disease||Intervention/treatment||Phase|
|Adrenal Insufficiency||Drug: Dexamethasone Other: Placebo||Phase 4|
Purpose To examine the effect of dexamethasone, on plasma cortisol levels, postoperative pain, nausea and vomiting in patients undergoing thyroid surgery.
Hypothesis That dexamethasone administered at induction of anesthesia will result in reduced plasma cortisol levels, postoperative pain, nausea and vomiting.
Justification Dexamethasone is a synthetic steroid medication used routinely to prevent nausea and vomiting in patients undergoing general anesthetic. Administration of exogenous steroids can suppress production of endogenous steroids including cortisol.
Currently, no data exists describing the degree of suppression of cortisol production by a single preoperative dose of dexamethasone. This information would guide physicians prescribing dexamethasone in the perioperative period.
Objectives To compare plasma cortisol levels in patients receiving dexamethasone versus placebo at induction of anesthesia. To investigate the effect of dexamethasone on postoperative pain, nausea and vomiting.
Research Methods A prospective, randomized, controlled, double-blinded study conducted at a single center. Thirty patients will be recruited and randomly assigned to dexamethasone or placebo groups, in accordance with sample size calculations. A placebo group is necessary to eliminate the effects of potential confounding factors.
Statistical Analysis An interim analysis will be conducted to confirm the sample size calculation. Plasma cortisol level will be analyzed using 2-way analysis of variance (ANOVA). Secondary outcome measures will be analyzed with appropriate parametric or nonparametric methods.
|Study Type :||Interventional (Clinical Trial)|
|Actual Enrollment :||0 participants|
|Intervention Model:||Parallel Assignment|
|Masking:||Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|
|Official Title:||The Effect of Dexamethasone on Plasma Cortisol Levels, Pain and PONV in Female Patients Undergoing Thyroid Surgery|
|Study Start Date :||May 2010|
|Estimated Primary Completion Date :||February 2014|
|Estimated Study Completion Date :||February 2016|
U.S. FDA Resources
One dose of 8 mg of Dexamethasone intravenously at induction of anesthesia
|Placebo Comparator: Placebo||
2 ml of 0.9% Saline Solution administered intravenously at induction of anesthesia
- Plasma Cortisol level. [ Time Frame: One, eight and twenty-four hours following Dexamethasone administration. ]
- Incidence of postoperative nausea and vomiting. [ Time Frame: Twenty-four hours following surgery. ]
- Pain intensity measured on the visual analogue scale. [ Time Frame: Twenty-four hours following surgery ]
- Plasma Estradiol level. [ Time Frame: One, eight and twenty-four hours following dexamethasone administration. ]
- Plasma Progesterone level. [ Time Frame: One, eight and twenty-four hours following dexamethasone administration ]
- Plasma ACTH level [ Time Frame: One, eight and twenty-four hours following dexamethasone administration. ]
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01045876
|Canada, British Columbia|
|St Paul's Hospital|
|Vancouver, British Columbia, Canada, V6Z 1Y6|
|Principal Investigator:||Jill A Osborn, MD||St Paul's Hospital, Vancouver and University of British Columbia|